The importance of co-delivery of nanoparticle-siRNA and anticancer agents in cancer therapy.

According to global statistics, cancer is the second leading cause of death worldwide. Because of the heterogeneity of cancer, single-drug therapy has many limitations due to low efficacy. Therefore, combination therapy with two or more therapeutic agents is being arisen.